Apparent Induction of Partial Thymic Regeneration in a Normal Human Subject: A Case Report

Journal of Anti-Aging Medicine

Volumn 6, Issue 3, 2003, Pages 219-227

  Fahy, Gregory M ^a  

^a Intervene Biomedical   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN GROWTH HORMONE; PRASTERONE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELDERLY CARE; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERPLASIA; IMAGE ANALYSIS; IMMUNE FUNCTION TEST; INVOLUTION; MALE; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORGAN SIZE; PRIORITY JOURNAL; THYMUS; TISSUE REGENERATION;

EID: 0842304721     PISSN: 10945458     EISSN: None     Source Type: Journal    
DOI: 10.1089/109454503322733063     Document Type: Article

References (87)

1. Roberts-Thomson I, Whittingham S, Youngchaiyud U, et al. Aging, immune response and mortality. Lancet 1974;2:368-370.
2. Murasko DM, Weiner P, Kaye D. Decline in mitogen induced proliferation of lymphocytes with increasing age. Clin Exp Immunol 1987;70:440-448.
3. Murasko DM, Weiner P, Kaye D. Association of lack of mitogen induced lymphocyte proliferation with increased mortality in the elderly. Aging Immunol Infect Dis 1988;1:1-6.
4. MacKay IR, Whittingham SF, Mathews JD. The immunoepidemiology of aging. In: Makinodan T, Yunis E, eds. Immunology and Aging. New York: Plenum, 1977:35-49.
5. Goldstein AL, Thurman GB, Low TLK, et al. Thymosin: the endocrine thymus and its role in the aging process. Aging 1979;81:51-60.
6. Makinodan T, Good RA, Kay MMB. Cellular basis of immunosenescence. In: Makinodan T, Yunis F, eds. Immunology and Aging. New York: Plenum, 1977:9-22.
7. Aspinall R, Andrew D. Thymic atrophy in the mouse is a soluble problem of the thymic environment. Vaccine 2000;18:1629-1637.
8. Aspinall R, Andrew D. Thymic involution in aging. J Clin Immunol 2000;20:250-256.
9. Effros RB. Genetic alterations in he ageing immune system: impact on infection and cancer. Mech Ageing Dev 2003;124:71-77.
10. Cawthon RM, Smith KR, O'Brien E, et al. Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003;361:393-395.
11. Fernandes G, Good RA, Yunis EJ. Attempts to correct age-related immunodeficiency and autoimmunity by cellular and dietary manipulation in inbred mice. In: Makinodan T, Yunis E, eds. Immunology and Aging. New York: Plenum, 1977:111-133.
12. Cao SX, Dhahbi JM, Mote PL, et al. Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice. Proc Natl Acad Sci USA 2001;98:10630-10635.
13. Lee CK, Weindruch R, Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet 2000;25:294-297.
14. Fabris N, Mocchegiani E, Muzzioli M, et al. Neuroendocrine-thymus interactions: perspectives for intervention in aging. Ann NY Acad Sci 1988;521:72-87.
15. Pieri C, Giuli C, del Moro M, et al. Electron-microscopic morphometric analysis of mouse liver. II. Effect of ageing and thymus transplantation in old animals. Mech Ageing Dev 1980;13:275-283.
16. Piantanelli L, Basso A, Muzzioli M, et al. Thymus-dependent reversibility of physiological and isoproterenol evoked age-related parameters in athymic (nude) and old normal mice. Mech Ageing Dev 1978;7:171-182.
17. Piantanelli L, Gentile S, Fattoretti P, et al. Thymic regulation of brain cortex beta-adrenoceptors during development and aging. Arch Gerontol Geriatr. 1985;4:179-185.
18. Hirokawa K, Utsuyama M. The effect of sequential multiple grafting of syngeneic newborn thymus on the immune functions and life expectancy of aging mice. Mech Ageing Dev 1984;28:111-121.
19. Fabris N, Pierpaoli W, Sorkin E. Lymphocytes, hormones, and ageing. Nature 1972;240:557-559.
20. Cardarelli NF. Involution, age, and puberty. In: Cardarelli NF, ed. The Thymus in Health and Senescence, Volum 1, Thymus and Immunity. Boca Raton, FL: CRC Press, 1989:51-57.
21. Grossman CJ. Interactions between the gonadal hormones and the immune system. Science 1985;227:257-261.
22. Fitzpatrick FTA, Kendall MD, Wheeler MJ, et al. Reappearance of the thymus of ageing rats after orchidectomy. J Endocrinol 1985;106:R17-R19.
23. Greenstein BD, Fitzpatrick FTA, Adcock IM, et al. Reappearance of the thymus in old rats after orchidectomy: inhibition of regeneration by testosterone. J Endocrinol 1986;110:417-422.
24. Greenstein BD, de Bridges EF, Fitzpatrick FTA. Aromatase inhibitors regenerate the thymus in aging male rats. Int J Immunopharmacol 1992;14:541-553.
25. Tibbetts TA, DeMayo F, Rich S, et al. Progesterone receptors in the thymus are required for thymic involution during pregnancy and for normal fertility. Proc Natl Acad Sci USA 1999;96:12021-12026.
26. Bilder GE. Effect of endocrine manipulation on graft rejection. Immunol Commun 1976;5:163-179.
27. Franks CR, Perkins FT, Bishop D. The effect of sex hormones on the growth of HeLa tumor nodules in male and female mice. Br J Cancer 1974;31:100-110.
28. Graf RJ, Lappe MA, Snell GD. The influence of the gonads and the adrenal glands on the immune response to skin grafts. Transplantation 1969;7:105-111.
29. Greenstein BD, Fitzpatrick FTA, Kendall MD, et al. Regeneration of the thymus in old male rats treated with a stable analogue of LHRH. J Endocrinol 1987;112:345-350.
30. Weinberg ED. Pregnancy-associated depression of cell-mediated immunity. Rev Infect Dis 1984;6:814-831.
31. Fabris N, Mocchegiani E, Muzzioli M, et al. Zinc, immunity, and aging. In: Goldstein AL, ed. Biomedical Advances in Aging. New York: Plenum Press, 1990:271-281.
32. Simpson JG, Gray ES, Michie W, et al. The influence of preoperative drug treatment on the extent of hyperplasia of the thymus in primary thyrotoxicosis. Clin Exp Immunol 1975;22:249-255.
33. Villa-Verde DMA, de Mello-Coelho V, Farias-de-Oliveira DA, et al. Pleiotropic influence of triiodothyronine on thymus physiology. Endocrinology 1993;133:867-875.
34. Judd R, Bueso-Ramos C. Combined true thymic hyperplasia and lymphoid hyperplasia in Graves' disease. Pediatr Pathol 1990;10:829-836.
35. Burgess W, Liu Q, Zhou J, et al. The immune-endocrine loop during aging: role of growth hormone and insulin-like growth factor-1. Neuroimmunomodulation 1999;6:56-68.
36. Montecino-Rodriguez E, Clark R, Dorshkind K. Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology 1998;139:4120-4126.
37. Guler HP, Zapf J, Scheiwiller E, et al. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 1988;85:4889-4893.
38. Kelley KW, Meier WA, Minshall C, et al. Insulin growth factor-1 inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging. Ann NY Acad Sci 1998;840:518-524.
39. Kelley KW, Brief S, Westly HJ, et al. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA 1986;83:5663-5667.
40. Gof BL, Roth JA, Arp LH, et al. Growth hormone treatment stimulates thymulin production in aged dogs. Clin Exp Immunol 1987;68:580-587.
41. Bar-Dayan Y, Small M. Effect of bovine growth hormone administration on the pattern of thymic involution in mice. Thymus 1994;23:95-104.
42. McCormick KR, Haar JL, Taubenberger JK, et al. A murine model for regeneration of the senescent thymus using growth hormone therapy. Aging Immunol Infect Dis 1991;3:19-26.
43. Fahy GM, Short-term and long-term possibilities for interventive gerontology. Mt Sinai J Med 1991;58:328-340.
44. Fahy GM. A physiological view of aging and its implications for interventive gerontology. Age 1991;13:101(abst).
45. Hadden JW. Thymic endocrinology and prospects for treating thymic involution. In: Hadden JW, Szentivanyi A, eds. Immunopharmacology Reviews II. Vol. 2. New York: Plenum Press, 1995:353-370.
46. Aspinall R, Andrew D. Immunosenescence: potential causes and strategies for reversal. Biochem Soc Trans. 2000;28:250-254.
47. Rudman D, Feller AG, Nagraj HS, et al. Effect of human growth hormone in men over 60 years old. N Engl J Med 1990;323:1-6.
48. Blackman MR, Sorkin JD, Munzer T, et al. Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA 2002;288:2282-2292.
49. Rudman D, Feller AG, Cohn L, et al. Effects of human growth hormone on body composition in elderly men. Horm Res 1991;36:73-81.
50. Crist DM, Peake GT, Mackinnon LT, et al. Exogenous growth hormone treatment alters body composition and increases natural killer cell activity in women with impaired endogenous growth hormone secretion. Metabolism 1987;36:1115-1117.
51. Timsit J, Savino W, Safieh B, et al. Growth hormone and insulin-like growth factor-1 stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 1992;75:183-188.
52. Fahy GM. Growth hormone therapy and related methods and pharmaceutical compositions. U.S. patent no. 6,297,212 B1, October 2, 2001.
53. Marcus R, Butterfield G, Holloway L, et al. Effects of short-term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 1990;70:519-527.
54. Molina PL, Siegel MJ, Glazer HS. Thymic masses on MR imaging. Am J Roentgenol 1990;155:495-500.
55. Stark DD, Clark OH, Moss AA. Magnetic resonance imaging of the thyroid, thymus, and parathyroid glands. Surgery 1984;96:1083-1090.
56. Napolitano LA, Lo JC, Gotway MB, et al. Increased thymic mass and circulating naïve CD4 T cells in HIV-1-infected adults treated with growth hormone. AIDS 2002;15:1103-1111.
57. McCune JM, Loftus R, Schmidt DK, et al. High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection. J Clin Invest 1998;101:2301-2308.
58. Bazzoni N, Ambrosi B, Arosio M, et al. Acromegaly and thymic hyperplasia: a case report. J Endocrinol Invest 1990;13:931-935.
59. Lamberts SWJ, van den Beld AW, van der Lely A-j. The endocrinology of aging. Science 1997;278:419-424.
60. Zhao H, Grossman HB, Spitz MR, et al. Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk. J Urol 2003;169:714-717.
61. Riley V, Fitzmaurice MA. DHEA and thymus integrity in the mouse: In: Kalimi M, Regelson W, eds. The Biologic Rule of Dehydroepiandrosterone (DHEA). Berlin: Walter de Gruyter & Co., 1990:131-155.
62. Rudman D. Growth hormone, body composition, and aging. J Am Geriatr Soc 1985;33:800-807.
63. Steger RW, Bartke A, Cedim M. Premature ageing in transgenic mice expressing different growth hormone genes. J Reprod Fertil Suppl 1993;46:61-75.
64. Bartke A. Growth hormone and aging. Endocrine 1998;8:103-108.
65. Tatar M, Bartke A, Antebi A. The endocrine regulation of aging by insulin-like signals. Science 2003;299:1346-1351.
66. Longo VD, Finch CE. Evolutionary medicine: from dwarf model systems to healthy centenarians? Science 2003;299:1342-1346.
67. Holzenberger M, DuPont J, Ducos B, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 2003;421:182-187.
68. Finch CE, Kirkwood TBL. Chance, Development, and Aging. New York: Oxford University Press, 2000.
69. Miller SE, Hadfield MG. Developmental arrest during larval life and life-span extension in a marine mollusc. Science 1990;248:356-358.
70. Beck SD, Bharadwaj RK. Reversed development and cellular aging in an insect. Science 1972;178:1210-1211.
71. Klass M, Hirsh D. Non-ageing developmental variant of Caenorhabditis elegans. Nature 1976;260:523-525.
72. Naar EM, Bartke A, Majumdar SS, et al. Fertility of transgenic female mice expressing bovine growth hormone or human growth hormone variant genes. Biol Reprod 1991;45:178-187.
73. Steger RW, Bartke A, Parkening TA, et al. Effects of chronic exposure to bovine growth hormone (bGH) on the hypothalamic-pituitary axis in transgenic mice: relationship to the degree of expression of the PEPCK.bGH hybrid gene. Transgenics 1994;1:245-253.
74. Kimura KD, Tissenbaum HA, Liu Y, et al. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997;277:942-946.
75. Bluher M, Kahn BB, Kahn CR. Extended longevity in mice lacking the insulin receptor in adipose tissue. Science 2003;299:572-574.
76. Mauras N, Martinez V, Rina A, et al. Recombinant human insulin-like growth factor I has significant anabolic effects in adults with growth hormone receptor deficiency: studies on protein, glucose, and lipid metabolism. J Clin Endocrinol Metab 2000;85:3036-3042.
77. Khansari DN, Gustad T. Effects of long-term, low-dose growth hormone therapy on immune function and life expectancy of mice. Mech Ageing Dev 1991;57:87-100.
78. Kalu DN, Orhii PB, Chen C, et al. Aged-rodent models of long-term growth hormone therapy: lack of deleterious effect on longevity. J Gerontol A Biol Sci Med Sci 1998;53:B452-B463.
79. Everitt A. The effect of pituitary growth hormone on the aging male rat. J Gerontol 1959;14:415-424.
80. Coles LS, Harris SB. Coenzyme Q-10 and lifespan extension. In: Klatz RM, ed. Advances in Anti-Aging Medicine. Larchmont, NY: Mary Ann Liebert, 1996:205-215.
81. Abs R, Bengtsson BA, Hernberg-Stahl E, et al. GH replacement in 1034 growth hormone deficient hypopituitary adults: demographic and clinical characteristics, dosing and safety. Clin Endocrinol (Oxf) 1999;50:703-713.
82. Bailey CJ, Flatt PR. Hormonal control of glucose homeostasis during development and ageing in mice. Metabolism 1982;31:238-246.
83. Brown-Borg HM, Rakoczy SG. Catalase expression in delayed and premature aging mouse models. Exp Gerontol 2000;35:199-212.
84. Honda Y, Honda S. The daf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression in Caenorhabditis elegans. FASEB J 1999;13:1385-1393.
85. Hekimi S, Guarente L. Genetics and the specificity of the aging process. Science 2003;299:1351-1354.
86. Simon AF, Shih C, Mack A, et al. Steroid control of longevity in Drosophila melanogaster. Science 2003;299:1407-1410.
87. she adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309-313.